An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence

International Urogynecology Journal

Volumn 21, Issue 12, 2010, Pages 1471-1477

  Lose, Gunnar ^a   Sørensen, Helle Christina ^a   Axelsen, Susanne M ^b   Falconer, Christian ^c   Lobodasch, Kurt ^d   Safwat, Tosson ^e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c DANDERYD HOSPITAL   (Sweden)

^d DRK Hospital Chemnitz Rebenstein   (Germany)

^e University Hospital of Hartlepool   (United Kingdom)

Author keywords

Bulking; Mixed incontinence; Polyacrylamide hydrogel; Stress

Indexed keywords

BULKING AGENT; POLYACRYLAMIDE GEL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HEADACHE; HEMATURIA; HUMAN; HYDROGEL; INJECTION SITE PAIN; LACERATION; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE PROCEDURE; MIXED INCONTINENCE; MULTICENTER STUDY; OPEN STUDY; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; QUALITY OF LIFE; STRESS INCONTINENCE; TREATMENT OUTCOME; URGE INCONTINENCE; URINARY TRACT INFECTION; URINE RETENTION; VISUAL ANALOG SCALE;

EID: 78650005364     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-010-1214-1     Document Type: Article

References (34)

1. N Klarskov G Lose 2008 Urethral injection therapy: what is a mechanism of action? Neurourol Urodyn 8 789 792 10.1002/nau.20602
2. PH ter Meulen LC Berghmans FH Nieman PE van Kerrebroeck 2009 Effects of macroplastique implantation system for stress urinary incontinence and urethral hypermobility in women Int Urogynecol J Pelvic Floor Dysfunct 20 177 183 10.1007/s00192-008-0741-5 18936867
3. Keegan PE, Atiemo K, Cody J, McClinton S, Pickard R (2007) Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev CD003881
4. DR Henly DM Barrett TL Weiland MK O'Connor AA Malizia AJ Wein 1995 Particulate silicone for use in periurethral injections: local tissue effects and search for migration J Urol 153 2039 2043 1:STN:280:DyaK2M3ntFyhuw%3D%3D 10.1016/S0022-5347(01)67398-1 7752390
5. L Stothers SL Goldenberg 1998 Delayed hypersensitivity and systemic arthralgia following transurethral collagen injection for stress urinary incontinence J Urol 159 1507 1509 1:STN:280:DyaK1c3htlSjtw%3D%3D 10.1097/00005392-199805000-00025 9554343
6. E Hurtado R McCrery R Appell 2007 The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency Int Urogynecol J Pelvic Floor Dysfunct 18 869 873 10.1007/s00192-006-0251-2 17103121
7. T Hagemeier U Blau A Gauruder-Burmester R Tunn 2006 Paraurethral abscess developing after mid-urethral Zuidex-injection in women with stress urinary incontinence-management of complications and retrospective comparison with bladder neck located injection technique Zentralbl Gynäkol 128 68 70 1:STN:280:DC%2BD283kvFOhsw%3D%3D 10.1055/s-2006-921343 16673247
8. MT Castillo-Vico MA Checa-Vizcaino A Paya-Panades C Rueda-Garcia R Carreras-Collado 2007 Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence Int Urogynecol J Pelvic Floor Dysfunct 18 95 97 10.1007/s00192-005-0049-7 16328113
9. S Madjar AK Sharma WC Waltzer Z Frischer CL Secrest 2006 Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence J Urol 175 1408 1410 1:CAS:528:DC%2BD28XjtlWkurY%3D 10.1016/S0022-5347(05)00679-8 16516009
10. S Bedir M Kilciler Y Ozgok G Deveci D Erduran 2004 Long-term complication due to dextranomer based implant: granuloma causing urinary obstruction J Urol 172 247 248 10.1097/01.ju.0000129006.16287.06 15201785
11. PC Palma CL Riccetto MH Martins V Herrmann R de Fraga A Billis, et al. 2006 Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence Int. Urogynecol. J Pelvic. Floor. Dysfunct. 17 670 671 10.1007/s00192-005-0038-x 16341621
12. G Lose L Mouritsen JB Nielsen 2006 A new bulking agent (polyacrylamide hydrogel) for treating stress urinary incontinence in women BJU Int 98 100 104 1:CAS:528:DC%2BD28XnslSrtrc%3D 10.1111/j.1464-410X.2006.06205.x 16831152
13. G Bello IT Jackson M Keskin C Kelly K Dajani R Studinger, et al. 2007 The use of polyacrylamide gel in soft-tissue augmentation: an experimental assessment Plast Reconstr Surg 119 1326 1336 1:CAS:528:DC%2BD2sXjvVSms7s%3D 10.1097/01.prs.0000254824.13065.3b 17496608
14. E Zarini R Supino G Pratesi D Laccabue M Tortoreto E Scanziani G Ghisleni S Paltrinieri G Tunesi M Nava 2004 Biocompatibility and tissue interactions of a new filler material for medical use Plast Reconstr Surg 114 934 10.1097/01.PRS.0000133425.22598.D0 15468401
15. LH Christensen VB Breiting A Aasted A Jorgensen I Kebuladze 2003 Long-term effects of polyacrylamide hydrogel on human breast tissue Plast Reconstr Surg 111 1883 1890 10.1097/01.PRS.0000056873.87165.5A 12711948
16. LH Christensen JB Nielsen L Mouritsen M Sorensen G Lose 2008 Tissue integration of polyacrylamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig Dermatol Surg 34 Suppl 1 S68 S77 1:CAS:528:DC%2BD1cXotVaqtrs%3D 10.1111/j.1524-4725.2008.34246.x 18547185
17. EA Smith FW Oehme 1991 Acrylamide and polyacrylamide: a review of production, use, environmental fate and neurotoxicity Rev Environ Health 9 215 228 1:CAS:528:DyaK3sXos1Gjsg%3D%3D 1668792
18. Pallua N, Wolter TP (in press) A 5 year assessment of safety and aesthetic results after facial soft-tissue augmentation with Polyacrylamide Hydrogel (Aquamid©): A prospective multicenter study of 251 patients. PRS
19. P Abrams L Cardozo M Fall D Griffiths P Rosier U Ulmsten, et al. 2002 The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 167 178 10.1002/nau.10052 11857671
20. K Avery J Donovan TJ Peters C Shaw M Gotoh P Abrams 2004 ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence Neurourol Urodyn 23 322 330 10.1002/nau.20041 15227649
21. B Stach-Lempinen E Kujansuu P Laippala R Metsanoja 2001 Visual analogue scale, urinary incontinence severity score and 15 D-psychometric testing of three different health-related quality-of-life instruments for urinary incontinent women Scand J Urol Nephrol 35 476 483 1:STN:280: DC%2BD387hsFGksQ%3D%3D 10.1080/003655901753367587 11848427
22. EMEA (2002) Note for guidance on the clinical investigation of medicinal products for treatment of urinary incontinence. CPMP/EWP/18/01 final, 1-7. Directive 75/318/EEC
23. CR Chapple F Haab M Cervigni C Dannecker A Fianu-Jonasson AH Sultan 2005 An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence Eur Urol 48 488 494 1:CAS:528:DC%2BD2MXhtFSks7%2FP 15967568
24. Smith A (2005) Surgery for urinary incontinence in women. In: Abrams P, Cardozo L, Khoury S, and Wein A, (eds). International Consultation on incontinence, pp 1319-1323
25. K Lobodasch 2010 Transurethral Injections with Bulkamid. Initial Clinical Results Geburtshilfe Frauenheilkd 70 47 51 10.1055/s-0029-1240759
26. CR Chapple AJ Wein L Brubaker R Dmochowski ME Pons F Haab, et al. 2005 Stress incontinence injection therapy: what is best for our patients? Eur Urol 48 552 565 10.1016/j.eururo.2005.06.012 16118034
27. D Robinson K Anders L Cardozo J Bidmead A Dixon J Balmforth, et al. 2003 What Do Women Want?: Interpretation of the Concept of Cure J Pelvic Med Surg 9 273 277 10.1097/01.spv.0000095060.05452.3f
28. MJ Caulfield, et al. 2002 Some Aspects of the Properties and Degradation of Polyacrylamide Chem Rev 102 3067 3083 1:CAS:528:DC%2BD38Xls1yqtLY%3D 10.1021/cr010439p 12222982
29. International Agency for Research on Cancer (IARC) (1994) On-line summary of acrylamide evaluation. World Health Organization
30. Integrated Risk Information System (IRIS) (1993) Acrylamide. U.S. Environmental Protection Agency.
31. RA Appell RR Dmochowski S Herschorn 2006 Urethral injections for female stress incontinence BJU Int 98 Suppl 1 27 30 1:CAS:528:DC%2BD28XhtVaktrrK 10.1111/j.1464-410X.2006.06305.x 16911598
32. EA Elzayat G Karsenty TA Bismar J Corcos 2008 Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats Int Urogynecol J Pelvic Floor Dysfunct 19 247 252 10.1007/s00192-007-0414-9 17639343
33. J Brahm R Lessel S Ditlev R Schmidt 2008 Determination of water and solute transport in polyacrylamide gels Macromol Symp 266 63 67 1:CAS:528:DC%2BD1cXoslyksbY%3D 10.1002/masy.200850612
34. A Kuhn W Stadlmayr D Lengsfeld MD Mueller 2008 Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct 19 817 821 10.1007/s00192-007-0535-1 18157642